Jupiter Life Line Hospitals Q1 profit falls 14.6 pc
Mumbai, July 31
Multi-speciality hospital chain Jupiter Life Line Hospitals Limited on Friday reported a 14.6 per cent year-on-year decline in its consolidated net profit for the quarter ended June 30, as losses from the newly commissioned Dombivli hospital and higher launch-related marketing expenses weighed on profitability.
The company posted a net profit of Rs 37.5 crore in the April-June quarter, compared with Rs 43.9 crore in the corresponding period last financial year (Q1 FY26), according to its stock exchange filing.
Commenting on financial results, Dr. Ankit Thakker MD & CEO said that the Dombivli hospital completed its first full quarter of operations, occupancy has been increasing steadily, supported by increasing patient footfall, expansion of clinical services and growing patient acceptance.
"We have also initiated process of insurance empanelment, which is expected to further improve patient inflows in the coming quarters. In line with our phased development strategy, we continue to add new specialties, strengthen our consultant base and expand service offerings to support a steady ramp-up," he added.
Revenue from operations, however, increased 16.4 per cent year-on-year to Rs 411 crore from Rs 353 crore, driven by growth in patient volumes across its hospital network.
At the operating level, EBITDA rose marginally by 1.1 per cent to Rs 79.3 crore from Rs 78.4 crore in the year-ago period.
However, the EBITDA margin contracted to 19.3 per cent from 22.2 per cent, it added in its regulatory filing.
Jupiter Life said the EBITDA performance was impacted by the initial ramp-up losses at its Dombivli hospital and higher marketing expenditure incurred during the launch phase.
The Dombivli facility reported an operational EBITDA loss of Rs 9.5 crore during the quarter, broadly in line with the Rs 9.4 crore loss recorded in the preceding quarter, as the hospital remained in the early stages of operations.
During the quarter, Jupiter Hospital Pharmacy Private Limited (JHPPL), a subsidiary of Jupiter Life, acquired 100 per cent equity share capital of Sulcus Private Limited for Rs 3.78 crore.
Following the transaction, Sulcus has become a wholly owned subsidiary of JHPPL and a step-down subsidiary of Jupiter Life.
— IANS
Reader Comments
Healthcare stocks are always a long-term game. The Dombivli hospital will take time to break even, just like any new venture. Good that they're focusing on insurance empanelment now - that's a smart move for patient inflow in the Thane belt.
The problem with Indian healthcare stocks is that they expand too fast and forget profitability. 14.6% profit decline is no joke. Hope the management is not just chasing growth at the expense of shareholder returns. Need to watch the next two quarters closely.
But profit fell while revenue rose? That's the classic Indian story of expansion eating into margins. Still, 19.3% EBITDA margin is decent for a hospital chain. The Dombivli catchment area is dense with population - wait till it ramps up fully, then you'll see the real growth. 😊
Smart move acquiring Sulcus Pharmacy - vertical integration in pharma will help control costs in the long run. The Dombivli loss is temporary. MUMBAI and THANE markets are underserved for quality multispeciality care. I'm holding my position.
Hospital stocks are essential for India's growth story but this 9.5 crore loss at Dombivli is concerning. Marketing spends during launch are fine, but need to see if this translates into occupancy. Hope they're not just burning cash for visibility. 🤔
We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.